The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
出版年份 2017 全文链接
标题
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue -, Pages 15503
出版商
Springer Nature
发表日期
2017-05-26
DOI
10.1038/ncomms15503
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites
- (2016) S. C. Melkonian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
- (2016) Shawn M. Davidson et al. Cell Metabolism
- WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenylm-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site
- (2016) Ogooluwa A. Ojelabi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
- (2016) Emma M. Kerr et al. NATURE
- Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers
- (2016) Guoli Chen et al. Translational Cancer Research
- LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
- (2015) Fuming Li et al. CANCER CELL
- Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers
- (2015) M. Momcilovic et al. CANCER RESEARCH
- Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
- (2015) M. Robertson-Tessi et al. CANCER RESEARCH
- Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer
- (2015) Johan F. Vansteenkiste et al. Journal of Thoracic Oncology
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
- (2015) Woo Hee Choi et al. TECHNOLOGY AND HEALTH CARE
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
- (2014) Olga C.J. Schuurbiers et al. Journal of Thoracic Oncology
- Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1
- (2014) B. Faubert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
- (2013) David B. Shackelford et al. CANCER CELL
- Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
- (2013) Hiroko Endo et al. Journal of Thoracic Oncology
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Glucose transporters in cancer metabolism
- (2012) Kehinde Adekola et al. CURRENT OPINION IN ONCOLOGY
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy
- (2012) Alexander Drilon et al. LANCET ONCOLOGY
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
- (2012) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Histological Subtypes of Lung Adenocarcinoma Have Differential 18F-Fluorodeoxyglucose Uptakes on the Positron Emission Tomography/Computed Tomography Scan
- (2011) Chao-Hua Chiu et al. Journal of Thoracic Oncology
- Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
- (2011) Tineke W.H. Meijer et al. LUNG CANCER
- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
- (2011) V. S. Rodrik-Outmezguine et al. Cancer Discovery
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Metabolism strikes back: metabolic flux regulates cell signaling
- (2010) C. M. Metallo et al. GENES & DEVELOPMENT
- Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
- (2010) Adi F. Gazdar et al. JNCI-Journal of the National Cancer Institute
- mTOR and HIF-1 -mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
- (2009) D. B. Shackelford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
- (2008) H. Yamamoto et al. CANCER RESEARCH
- First-Line Chemotherapy for Non–Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology?
- (2008) Lawrence H. Einhorn JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study
- (2008) Kwang-Ho In et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started